Hong Ouyang

Toronto, ON, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Nasal cells as a bronchial cell surrogate for pre-clinical assessment of drug response in cystic fibrosis.

Nasal cells as a bronchial cell surrogate for pre-clinical assessment of drug response in cystic fibrosis.

Journal: Frontiers in pharmacology

Published: June 20, 2025

Pathogenesis and transmission of SARS-CoV-2 D614G, Alpha, Gamma, Delta, and Omicron variants in golden hamsters.

Pathogenesis and transmission of SARS-CoV-2 D614G, Alpha, Gamma, Delta, and Omicron variants in golden hamsters.

Journal: Npj viruses

Published: August 12, 2024

Relationship between theratyping in nasal epithelial cells and clinical outcomes in people with cystic fibrosis.

Relationship between theratyping in nasal epithelial cells and clinical outcomes in people with cystic fibrosis.

Journal: The European respiratory journal

Published: April 16, 2024

Primary Human Nasal Epithelial Cell Culture.

Primary Human Nasal Epithelial Cell Culture.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: October 19, 2023

Rapid and inexpensive bedside diagnosis of RAN binding protein 2-associated acute necrotizing encephalopathy.

Rapid and inexpensive bedside diagnosis of RAN binding protein 2-associated acute necrotizing encephalopathy.

Journal: Frontiers in neurology

Published: August 23, 2023

Broad spectrum post-entry inhibitors of coronavirus replication: Cardiotonic steroids and monensin.

Broad spectrum post-entry inhibitors of coronavirus replication: Cardiotonic steroids and monensin.

Journal: Virology

Published: July 25, 2023

Correlation of Electrophysiological and Fluorescence-Based Measurements of Modulator Efficacy in Nasal Epithelial Cultures Derived from People with Cystic Fibrosis.

Correlation of Electrophysiological and Fluorescence-Based Measurements of Modulator Efficacy in Nasal Epithelial Cultures Derived from People with Cystic Fibrosis.

Journal: Cells

Published: March 03, 2023

Expression of cystic fibrosis lung disease modifier genes in human airway models.

Expression of cystic fibrosis lung disease modifier genes in human airway models.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

Published: September 08, 2021

Inflammatory epithelial cytokines after in vitro respiratory syncytial viral infection are associated with reduced lung function.

Inflammatory epithelial cytokines after in vitro respiratory syncytial viral infection are associated with reduced lung function.

Journal: ERJ open research

Published: June 02, 2021

Preclinical Studies of a Rare CF-Causing Mutation in the Second Nucleotide Binding Domain (c.3700A>G) Show Robust Functional Rescue in Primary Nasal Cultures by Novel CFTR Modulators.

Preclinical Studies of a Rare CF-Causing Mutation in the Second Nucleotide Binding Domain (c.3700A>G) Show Robust Functional Rescue in Primary Nasal Cultures by Novel CFTR Modulators.

Journal: Journal of personalized medicine

Published: October 12, 2020

Rescue of multiple class II CFTR mutations by elexacaftor+tezacaftor+ivacaftor mediated in part by the dual activities of elexacaftor as both corrector and potentiator.

Rescue of multiple class II CFTR mutations by elexacaftor+tezacaftor+ivacaftor mediated in part by the dual activities of elexacaftor as both corrector and potentiator.

Journal: The European respiratory journal

Published: April 11, 2020

The CFTR Mutation c.3453G > C (D1152H) Confers an Anion Selectivity Defect in Primary Airway Tissue that Can Be Rescued by Ivacaftor.

The CFTR Mutation c.3453G > C (D1152H) Confers an Anion Selectivity Defect in Primary Airway Tissue that Can Be Rescued by Ivacaftor.

Journal: Journal of personalized medicine

Published: April 09, 2020

Showing 1-12 of 24

Last Updated: 09/26/2026